Laura S Leddy1. 1. Memorial Sloan-Kettering Cancer Center, 353 East 68th Street, New York, NY, 10065, USA. leddyl@mskcc.org.
Abstract
PURPOSE OF REVIEW: To present the available literature pertaining to the management of lower urinary tract symptoms (LUTS) after pelvic radiation (RT) in female patients treated for pelvic malignancy. RECENT FINDINGS: Recent publications have focused on isolating de novo RT-induced LUTS in women from other contributors to urinary symptoms such as pelvic surgery and chemotherapy. There is a paucity of literature on the treatment of RT-related changes to urinary function. The treatment of pelvic malignancies in women alters voiding function. RT contributes to the deterioration of voiding function. More study is needed to evaluate the efficacy of available therapies.
PURPOSE OF REVIEW: To present the available literature pertaining to the management of lower urinary tract symptoms (LUTS) after pelvic radiation (RT) in female patients treated for pelvic malignancy. RECENT FINDINGS: Recent publications have focused on isolating de novo RT-induced LUTS in women from other contributors to urinary symptoms such as pelvic surgery and chemotherapy. There is a paucity of literature on the treatment of RT-related changes to urinary function. The treatment of pelvic malignancies in women alters voiding function. RT contributes to the deterioration of voiding function. More study is needed to evaluate the efficacy of available therapies.
Authors: Rodney Davis; J Stephen Jones; Daniel A Barocas; Erik P Castle; Erich K Lang; Raymond J Leveillee; Edward M Messing; Scott D Miller; Andrew C Peterson; Thomas M T Turk; William Weitzel Journal: J Urol Date: 2012-10-24 Impact factor: 7.450
Authors: Linda Åkeflo; Gail Dunberger; Eva Elmerstig; Viktor Skokic; Gunnar Steineck; Karin Bergmark Journal: BMJ Open Date: 2021-07-21 Impact factor: 2.692
Authors: A Holmqvist; A Axelsson; R Mikivier; K Redelius; U Odelram Wiréen; S Uppugunduri Journal: Clin Transl Oncol Date: 2021-03-08 Impact factor: 3.405